Glenmark Pharmaceuticals’ Abiraterone Acetate tablets receive ANDA approval
November 2019Glenmark Pharmaceuticals Inc. has been granted abbreviated new drug application (ANDA) approval by the US Food & Drug Administration (USFDA) for its Abiraterone Acetate tablets USP, 250 mg, a generic…Read More